|
National Stock Number(NSN): 6505-01-052-0508 (6505010520508, 010520508)
| NIIN: |
01-052-0508 |
Item Name: |
SULFACETAMIDE SODIUM OPHTHALMIC SOLUTION |
INC: |
26528
|
| FSC: |
6505
|
Assignment Date: |
Dec-09-1977 |
CRIT: |
X |
IIG: |
26528 |
| ISC: |
5 |
Date Standardized: |
Dec-09-1977 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9285 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
58-0786-10 |
24489
|
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV |
H |
3 |
9 |
4 |
75 |
1 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 PERCENTAGE, W/V SULFACETAMIDE SODIUM ACTIVE INGREDIENT |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
AQUEOUS |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE, DROPPER |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|